KCTD21
BTB/POZ domain-containing protein KCTD21
Also known as: KCASH2, KCD21_HUMAN
Cross-references: UniProt · Ensembl · Human Protein Atlas · GeneCards · NCBI Gene
Protein identityUniProt · HPA
- UniProt accession
- Q4G0X4
- Gene
- KCTD21
- Ensembl
- ENSG00000188997
- Chromosome
- 11
- Canonical length
- 260 aa
- Protein class
- Predicted intracellular proteins
- Subcellular location
- Cytosol
- Quaternary structure
- Homopentamer
OverviewNCBI Gene
Enables cullin family protein binding activity; histone deacetylase binding activity; and identical protein binding activity. Involved in negative regulation of smoothened signaling pathway and ubiquitin-dependent protein catabolic process. [provided by Alliance of Genome Resources, Jul 2025]
Canonical amino-acid sequenceUniProt
260 residues, UniProt reviewed canonical sequence.
>Q4G0X4|KCTD21
1 MSDPITLNVG GKLYTTSLAT LTSFPDSMLG AMFSGKMPTK RDSQGNCFID RDGKVFRYIL
61 NFLRTSHLDL PEDFQEMGLL RREADFYQVQ PLIEALQEKE VELSKAEKNA MLNITLNQRV
121 QTVHFTVREA PQIYSLSSSS MEVFNANIFS TSCLFLKLLG SKLFYCSNGN LSSITSHLQD
181 PNHLTLDWVA NVEGLPEEEY TKQNLKRLWV VPANKQINSF QVFVEEVLKI ALSDGFCIDS
241 SHPHALDFMN NKIIRLIRYRLocalizationUniProt · AlphaFold · HPA
Whether an antibody against KCTD21 can act on the native protein depends on physical access: surface and secreted proteins are reachable by circulating antibodies, intracellular proteins usually are not.
- Antibody reachability
- Unknown
- Secreted
- No
- Transmembrane segments
- 0
- Mean surface accessibility (rSASA)
- 0.3
- Highest tissue expression
- 15 nTPM
Expression across tissuesHPA
Tissue
- liver: 15 nTPM
- adrenal gland: 13 nTPM
- midbrain: 11 nTPM
- thyroid gland: 10 nTPM
- ovary: 10 nTPM
- blood vessel: 10 nTPM
Single-cell type
- adrenal medulla cells: 32 nCPM
- esophageal apical cells: 29 nCPM
- adrenal cortex cells: 26 nCPM
- neutrophils: 21 nCPM
- gonadotrophs: 19 nCPM
- esophageal suprabasal cells: 16 nCPM
Immune cell
- neutrophil: 8.3 nTPM
- eosinophil: 7.5 nTPM
- intermediate monocyte: 6 nTPM
- classical monocyte: 5.4 nTPM
- non-classical monocyte: 5.1 nTPM
- myeloid DC: 3.7 nTPM
Brain region
- midbrain: 40 nTPM
- pons: 37 nTPM
- medulla oblongata: 36 nTPM
- hypothalamus: 35 nTPM
- white matter: 35 nTPM
- thalamus: 35 nTPM
Genetic constraint and essentialitygnomAD · DepMap
Does the body need this protein intact? Low LOEUF or a strong DepMap dependency means loss or blockade of the protein is likely to be felt.
- gnomAD LOEUF (loss-of-function intolerance)
- 1.68
- gnomAD pLI
- 0
- gnomAD missense Z
- 0.5
- DepMap mean gene effect
- -0.04
- DepMap dependency class
- selective
Cancer expressionTCGA
Across TCGA tumor cohorts, this protein is over-expressed in roughly 6% of surveyed tumor types (aggregate summary; per-cohort expression, alteration, and survival load in the interactive view).
OntologyGO
Biological processes
- negative regulation of smoothened signaling pathway
- protein homooligomerization
- protein ubiquitination
- ubiquitin-dependent protein catabolic process
Molecular functions
Protein domainsUniProt · Pfam · InterPro
KeywordsUniProt
InteractionsUniProt · HPA
Protein binding partners of KCTD21 in the human serome: UniProt-annotated complex subunits plus reported interactors. Each links to its own Seroatlas record.
Antibody and autoantibody relevanceSeroatlas analysis
Seroatlas reads KCTD21 as an antibody target. Whether an autoantibody or antibody against KCTD21 could matter depends on whether native KCTD21 is physically reachable, whether the body needs it intact, and whether it acts in a disease-relevant tissue.
KCTD21 is annotated as predominantly intracellular. Intracellular proteins are common autoantibody markers, becoming visible to the immune system after cell injury or altered processing, but are usually markers of disease rather than direct drivers.
Annotation status
The present source text does not explicitly label KCTD21 as an autoantigen. Seroatlas presents hypothesis context only and does not manufacture a known-serology claim.
Loading the interactive Seroatlas protein explorer...